Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
about
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical reviewNeutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-AnalysisLack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical ProstatectomyRole of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillancePrognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
P2860
Q28073742-565BCFD0-7622-43F0-B6C9-4BEF6D7EADA1Q28552296-D7CAD289-67B0-4A10-A903-07C8F6770FDFQ36864218-0C0D2FA9-B2A9-4D15-BE6B-0B4B82D2ED24Q37585270-357F1F89-9ADB-4B5D-BE8C-96E295A70E86Q38623275-2A13A1D6-D107-4967-B8E5-A3A0123F52AAQ38941692-7F648297-77EE-4DFA-A197-9CCC0392FD27Q39041165-A533F87E-DB1F-403F-B1B4-D989858F4FFCQ39651226-90606517-40D4-434F-BE0F-39985135023DQ40460665-549C50B0-C255-48CC-869B-FD1FC27E70CDQ41625490-8A03794E-A9A5-4DFD-BD0B-9F6E780D10B6Q49919238-9EDA168D-BEE3-41A6-B150-15C88E542D92
P2860
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neutrophil and Lymphocyte Coun ...... ying Low-Risk Prostate Cancer.
@en
type
label
Neutrophil and Lymphocyte Coun ...... ying Low-Risk Prostate Cancer.
@en
prefLabel
Neutrophil and Lymphocyte Coun ...... ying Low-Risk Prostate Cancer.
@en
P2093
P2860
P1476
Neutrophil and Lymphocyte Coun ...... fying Low-Risk Prostate Cancer
@en
P2093
Christopher Sejong Han
Isaac Yi Kim
Ji Hae Park
Rachel Davis
Wun-Jae Kim
Young Suk Kwon
Yun-Sok Ha
P2860
P356
10.1016/J.CLGC.2015.07.018
P407
P577
2015-08-06T00:00:00Z